Identification of two novel ACAT1 variant associated with beta-ketothiolase deficiency in a 9-month-old boy
Author:
Wang Yujuan1, Gao Qian2, Wang Wei1, Xin Xiaowei1, Yin Yi1, Zhao Chun1, Jin Youpeng1ORCID
Affiliation:
1. Department of Pediatric Intensive Care Unit , Shandong Provincial Hospital Affiliated to Shandong First Medical University , Jinan , Shandong Province , P.R. China 2. Department of Pediatric Intensive Care Unit , Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University , Jinan , Shandong Province , P.R. China
Abstract
Abstract
Objectives
Mitochondrial acetoacetyl-CoA thiolase (beta-ketothiolase, T2) is necessary for the catabolism of ketone bodies andisoleucine. T2 deficiency is an autosomal recessive metabolic disorder caused by variant in the ACAT1 gene. In this report, we describe two novel ACAT1 variant identified in a Chinese family.
Case presentation
The 9-month-old male proband was admitted to the pediatric intensive care unit for altered consciousness. At the time of admission, the patient had acidosis, drowsiness, and respiratory failure. Both urine organic acid analyses and LC–MS/MS suggested T2 deficiency. Novel compound heterozygous variant (c.871G>C and c.1016_1017del) in the ACAT1 gene were detected in the proband by WES and verified through direct sequencing. Family analysis demonstrated that the first variant was transmitted from his father and the second variant was from his mother, indicating autosomal recessive inheritance. This report is the first to describe the association of these variant with T2 deficiency based on genetic testing. Although these variant were identified in the patient’s elder sister and elder brother, they continue to be asymptomatic.
Conclusions
We identified two novel ACAT1 variants associated with T2 deficiency. The identification expands the spectrum of known variant linked to the disorder.
Publisher
Walter de Gruyter GmbH
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism,Pediatrics, Perinatology and Child Health
Reference11 articles.
1. Fukao, T, Sasai, H, Aoyama, Y, Otsuka, H, Ago, Y, Matsumoto, H, et al.. Recent advances in understanding beta-ketothiolase (mitochondrial acetoacetyl-CoA thiolase, T2) deficiency. J Hum Genet 2019;64:99–111. https://doi.org/10.1038/s10038-018-0524-x. 2. Fukao, T, Yamaguchi, S, Kano, M, Orii, T, Fujiki, Y, Osumi, T, et al.. Molecular cloning and sequence of the complementary DNA encoding human mitochondrial acetoacetyl-coenzyme A thiolase and study of the variant enzymes in cultured fibroblasts from patients with 3-ketothiolase deficiency. J Clin Invest 1990;86:2086–92. https://doi.org/10.1172/jci114946. 3. Daum, RS, Lamm, PH, Mamer, OA, Scriver, CR. A “new” disorder of isoleucine catabolism. Lancet 1971;2:1289–90. https://doi.org/10.1016/s0140-6736(71)90605-2. 4. Fukao, T, Mitchell, G, Sass, JO, Hori, T, Orii, K, Aoyama, Y. Ketone body metabolism and its defects. J Inherit Metab Dis 2014;37:541–51. https://doi.org/10.1007/s10545-014-9704-9. 5. Hori, T, Yamaguchi, S, Shinkaku, H, Horikawa, R, Shigematsu, Y, Takayanagi, M, et al.. Inborn errors of ketone body utilization. Pediatr Int 2015;57:41–8. https://doi.org/10.1111/ped.12585.
|
|